These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 15753365)
1. Elevated serum levels of stromal-derived factor-1alpha are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients. Zannettino AC; Farrugia AN; Kortesidis A; Manavis J; To LB; Martin SK; Diamond P; Tamamura H; Lapidot T; Fujii N; Gronthos S Cancer Res; 2005 Mar; 65(5):1700-9. PubMed ID: 15753365 [TBL] [Abstract][Full Text] [Related]
2. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451 [TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor-1 (SDF-1) recruits osteoclast precursors by inducing chemotaxis, matrix metalloproteinase-9 (MMP-9) activity, and collagen transmigration. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2003 Aug; 18(8):1404-18. PubMed ID: 12929930 [TBL] [Abstract][Full Text] [Related]
4. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts. Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation. Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013 [TBL] [Abstract][Full Text] [Related]
6. Integrin alpha4beta1 involvement in stromal cell-derived factor-1alpha-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion. Parmo-Cabañas M; Bartolomé RA; Wright N; Hidalgo A; Drager AM; Teixidó J Exp Cell Res; 2004 Apr; 294(2):571-80. PubMed ID: 15023543 [TBL] [Abstract][Full Text] [Related]
7. An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors. Zannettino AC; Farrugia AN; To LB; Atkins GJ Methods Mol Med; 2005; 113():245-56. PubMed ID: 15968108 [TBL] [Abstract][Full Text] [Related]
8. Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. Liao TS; Yurgelun MB; Chang SS; Zhang HZ; Murakami K; Blaine TA; Parisien MV; Kim W; Winchester RJ; Lee FY J Orthop Res; 2005 Jan; 23(1):203-9. PubMed ID: 15607894 [TBL] [Abstract][Full Text] [Related]
9. Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin. Dorman SC; Babirad I; Post J; Watson RM; Foley R; Jones GL; O'Byrne PM; Sehmi R J Allergy Clin Immunol; 2005 Mar; 115(3):501-7. PubMed ID: 15753896 [TBL] [Abstract][Full Text] [Related]
10. Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cells. Kalinkovich A; Tavor S; Avigdor A; Kahn J; Brill A; Petit I; Goichberg P; Tesio M; Netzer N; Naparstek E; Hardan I; Nagler A; Resnick I; Tsimanis A; Lapidot T Cancer Res; 2006 Nov; 66(22):11013-20. PubMed ID: 17108140 [TBL] [Abstract][Full Text] [Related]
11. CXCL12 chemokine up-regulates bone resorption and MMP-9 release by human osteoclasts: CXCL12 levels are increased in synovial and bone tissue of rheumatoid arthritis patients. Grassi F; Cristino S; Toneguzzi S; Piacentini A; Facchini A; Lisignoli G J Cell Physiol; 2004 May; 199(2):244-51. PubMed ID: 15040007 [TBL] [Abstract][Full Text] [Related]
12. Human coronary microvascular effects of cardioplegia-induced stromal-derived factor-1alpha. Mieno S; Boodhwani M; Ramlawi B; Li J; Feng J; Bianchi C; Laham RJ; Li J; Sellke FW Ann Thorac Surg; 2006 Aug; 82(2):657-63. PubMed ID: 16863781 [TBL] [Abstract][Full Text] [Related]
13. Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma. Heider U; Langelotz C; Jakob C; Zavrski I; Fleissner C; Eucker J; Possinger K; Hofbauer LC; Sezer O Clin Cancer Res; 2003 Apr; 9(4):1436-40. PubMed ID: 12684416 [TBL] [Abstract][Full Text] [Related]
14. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma]. Zhang C; Cui GH; Liu F; Wu QL; Chen Y Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309 [TBL] [Abstract][Full Text] [Related]
15. SDF-1 increases recruitment of osteoclast precursors by upregulation of matrix metalloproteinase-9 activity. Yu X; Collin-Osdoby P; Osdoby P Connect Tissue Res; 2003; 44 Suppl 1():79-84. PubMed ID: 12952178 [TBL] [Abstract][Full Text] [Related]
16. [Expression of CXCR4 and its effect on the biological behavior of multiple myeloma cells]. Li CX; Wu DP; Wang YD; Yu GH; Liu JM; Zhuang YM; Yin CS; Zhang XG Zhonghua Xue Ye Xue Za Zhi; 2003 Mar; 24(3):122-5. PubMed ID: 12697121 [TBL] [Abstract][Full Text] [Related]
17. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Gazitt Y; Akay C Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392 [TBL] [Abstract][Full Text] [Related]
18. Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells. Pellegrino A; Ria R; Di Pietro G; Cirulli T; Surico G; Pennisi A; Morabito F; Ribatti D; Vacca A Br J Haematol; 2005 Apr; 129(2):248-56. PubMed ID: 15813853 [TBL] [Abstract][Full Text] [Related]
19. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway. Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299 [TBL] [Abstract][Full Text] [Related]
20. Thalidomide treatment down-regulates SDF-1alpha and CXCR4 expression in multiple myeloma patients. Oliveira AM; Maria DA; Metzger M; Linardi C; Giorgi RR; Moura F; Martinez GA; Bydlowski SP; Novak EM Leuk Res; 2009 Jul; 33(7):970-3. PubMed ID: 18976811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]